Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 694Treatment of Major DepressionPharmacogenetics and Drug MetabolismNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.

Tricyclic antidepressant pharmacology and therapeutic drug interactions updated

Open access
Gillman, P K·2007·British Journal of Pharmacology

Abstract

New data on the pharmacology of tricyclic antidepressants (TCAs), their affinities for human cloned CNS receptors and their cytochrome P450 enzyme inhibition profiles, allow improved deductions concerning their effects and interactions and indicate which of the TCAs are the most useful. The relative toxicity of TCAs continues to be more precisely defined, as do TCA interactions with selective serotonin reuptake inhibitors (SSRIs). TCA interactions with monoamine oxidase inhibitors (MAOIs) have been, historically, an uncertain and difficult question, but are now well understood, although this is not reflected in the literature. The data indicate that nortriptyline and desipramine have the most pharmacologically desirable characteristics as noradrenaline reuptake inhibitors (NRIs), and as drugs with few interactions that are also safe when coadministered with either MAOIs or SSRIs. Clomipramine is the only available antidepressant drug that has good evidence of clinically relevant serotonin and noradrenaline reuptake inhibition (SNRI). These data assist drug selection for monotherapy and combination therapy and predict reliably how and why pharmacodynamic and pharmacokinetic interactions occur. In comparison, two newer drugs proposed to have SNRI properties, duloxetine and venlafaxine, may have insufficient NRI potency to be effective SNRIs. Combinations such as sertraline and nortriptyline may therefore offer advantages over drugs like venlafaxine that have fixed ratios of SRI/NRI effects that are not ideal. However, no TCA/SSRI combination is sufficiently safe to be universally applicable without expert knowledge. Standard texts (e.g. the British National Formulary) and treatment guidelines would benefit by taking account of these new data and understandings. British Journal of Pharmacology (2007) 151 , 737–748; doi: 10.1038/sj.bjp.0707253

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0707253

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 132 references

Research works printed but not linked: 6

  1. 10.1002/(SICI)1520-6394(1997)5:2<84::AID-DA4>3.0.CO;2-5 · DOI
  2. 10.1002/(SICI)1520-6394(1998)7:1 <11::AID-DA4>3.0.CO;2-I · doi:10.1002/(sici)1520-6394(1998)7:1
  3. Brunton LL, 2006, Goodman and Gilman's The Pharmacologicl Basis of Therapeutics
  4. Dawson AH, 2004, Med Toxicol, 851
  5. Preskorn S, 2006, 2006 guide to psychiatric drug interactions, Primary Psychiatry, 13, 35
  6. Whyte IM, 2004, Med Toxicol, 843

Cited by

See all 694

Metadata

Authors
Gillman, P. K.
Affiliations
PsychoTropical Research (AU)
Corresponding author
Gillman, P K
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2007-07
Volume
151
Issue
6
Pages
737-748
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2155964805
Cited by
694
References
132
Citations by year
2026: 34 · 2025: 50 · 2024: 51 · 2023: 43 · 2022: 60 · 2021: 52 · 2020: 43 · 2019: 36 · 2018: 39 · 2017: 42 · 2016: 35 · 2015: 27 · 2014: 30 · 2013: 31 · 2012: 37
FWCI
12.92
Type
journal article
Language
en
Open access
Locations
  • British Journal of Pharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of Mental Health
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
tricyclic antidepressants, drug interactions, cytochrome P450 inhibition, nortriptyline, desipramine, clomipramine, selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, norepinephrine reuptake inhibition, duloxetine, venlafaxine, sertraline, combination therapy
MeSH terms
Animals, Antidepressive Agents, Tricyclic, Central Nervous System, Cytochrome P-450 Enzyme System, Drug Interactions, Drug Therapy, Combination, Humans, Monoamine Oxidase Inhibitors, Selective Serotonin Reuptake Inhibitors, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. https://app.cochat.ai/papers/10.1038/sj.bjp.0707253
The paper
Gillman, P. K. (2007). Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0707253

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.